<?xml version="1.0" encoding="UTF-8"?>
<clinical_study rank="28306">
  <!-- This xml conforms to an XML Schema at:
    http://clinicaltrials.gov/ct2/html/images/info/public.xsd
 and an XML DTD at:
    http://clinicaltrials.gov/ct2/html/images/info/public.dtd -->
  <required_header>
    <download_date>ClinicalTrials.gov processed this data on June 04, 2014</download_date>
    <link_text>Link to the current ClinicalTrials.gov record.</link_text>
    <url>http://clinicaltrials.gov/show/NCT01765816</url>
  </required_header>
  <id_info>
    <org_study_id>Gen-100-sub1</org_study_id>
    <nct_id>NCT01765816</nct_id>
  </id_info>
  <brief_title>Generation 100: Blood Volume and Cardiac Function in Healthy Aging</brief_title>
  <official_title>Generation 100: How Exercise Affects Mortality and Morbidity in the Elderly: A Randomized Control Study</official_title>
  <sponsors>
    <lead_sponsor>
      <agency>Norwegian University of Science and Technology</agency>
      <agency_class>Other</agency_class>
    </lead_sponsor>
  </sponsors>
  <source>Norwegian University of Science and Technology</source>
  <oversight_info>
    <authority>Norway: Regional Ethics Commitee</authority>
    <has_dmc>Yes</has_dmc>
  </oversight_info>
  <brief_summary>
    <textblock>
      Hypothesis:  Exercise will reduce morbidity and mortality rates in an elderly population.
      The extent of reduction will be intensity dependent.

      As part of the &quot;Generation 100&quot; study, this sub-study project will investigate the effect of
      exercise on blood volume, cardiopulmonary health and heart function in healthy aging.
      Objective is to determine the acute effect of one endurance training session on blood volume
      in healthy elderly. The working hypothesis is that one interval training session increases
      total blood volume by 10% in healthy elderly, and that there will be no change after
      moderate continuous training.
    </textblock>
  </brief_summary>
  <overall_status>Recruiting</overall_status>
  <start_date>August 2012</start_date>
  <completion_date type="Anticipated">August 2014</completion_date>
  <primary_completion_date type="Anticipated">February 2014</primary_completion_date>
  <phase>N/A</phase>
  <study_type>Interventional</study_type>
  <study_design>Allocation: Randomized, Intervention Model: Crossover Assignment, Masking: Open Label, Primary Purpose: Health Services Research</study_design>
  <primary_outcome>
    <measure>total blood volume</measure>
    <time_frame>24 hours</time_frame>
    <safety_issue>No</safety_issue>
    <description>carbon monoxide-rebreathing spirometry (Bayreuth, Germany)</description>
  </primary_outcome>
  <secondary_outcome>
    <measure>hemoglobin volume</measure>
    <time_frame>24 hours</time_frame>
    <safety_issue>No</safety_issue>
    <description>carbon monoxide-rebreathing spirometry (Bayreuth, Germany)</description>
  </secondary_outcome>
  <number_of_arms>2</number_of_arms>
  <enrollment type="Anticipated">25</enrollment>
  <condition>Ageing</condition>
  <arm_group>
    <arm_group_label>high intensity interval training</arm_group_label>
    <arm_group_type>Experimental</arm_group_type>
    <description>one interval training session with 1 x 4 and 4 x 4 minutes interval training at 90-95% of peak heart rate</description>
  </arm_group>
  <arm_group>
    <arm_group_label>moderate intensity training</arm_group_label>
    <arm_group_type>Active Comparator</arm_group_type>
    <description>45 minutes of moderate continuous training at 75% of maximal heart rate</description>
  </arm_group>
  <intervention>
    <intervention_type>Behavioral</intervention_type>
    <intervention_name>high intensity interval training</intervention_name>
    <arm_group_label>high intensity interval training</arm_group_label>
    <arm_group_label>moderate intensity training</arm_group_label>
  </intervention>
  <intervention>
    <intervention_type>Behavioral</intervention_type>
    <intervention_name>moderate intensity training</intervention_name>
    <arm_group_label>high intensity interval training</arm_group_label>
    <arm_group_label>moderate intensity training</arm_group_label>
  </intervention>
  <eligibility>
    <criteria>
      <textblock>
        Inclusion Criteria:

          -  ability to walk at least 1km,

          -  born in 1938,1939,1940,1941 or 1942

          -  Sufficiently good health to be able to take part in the study, as determined by the
             researchers

        Exclusion Criteria:

          -  Illness or disability that precludes exercise or hinders completion of the study

          -  Uncontrolled hypertension

          -  Symptomatic valve disease, hyper tropic cardio-myopathy or unstable angina

          -  Active cancer

          -  Test results indicating that study participation is unsafe

          -  Inclusion in other studies conflicting with participation in this one
      </textblock>
    </criteria>
    <gender>Both</gender>
    <minimum_age>70 Years</minimum_age>
    <maximum_age>75 Years</maximum_age>
    <healthy_volunteers>Accepts Healthy Volunteers</healthy_volunteers>
  </eligibility>
  <overall_official>
    <last_name>Ulrik Wisløff, Professor</last_name>
    <role>Study Chair</role>
    <affiliation>Norwegian University of Science and Technology</affiliation>
  </overall_official>
  <overall_contact>
    <last_name>Trine Karlsen, PhD</last_name>
    <phone>0047 72828058</phone>
    <email>trine.karlsen@ntnu.no</email>
  </overall_contact>
  <location>
    <facility>
      <name>Norwegian University of Science and Technology</name>
      <address>
        <city>Trondheim</city>
        <zip>7006</zip>
        <country>Norway</country>
      </address>
    </facility>
    <status>Recruiting</status>
    <contact>
      <last_name>Trine Karlsen, PhD</last_name>
      <phone>0047 72828058</phone>
      <email>trine.karlsen@ntnu.no</email>
    </contact>
    <contact_backup>
      <last_name>Ulrik Wisløff, PhD prof</last_name>
      <phone>0047 7288113</phone>
      <email>ulrik.wisloff@ntnu.no</email>
    </contact_backup>
    <investigator>
      <last_name>Trine Karlsen, PhD</last_name>
      <role>Principal Investigator</role>
    </investigator>
  </location>
  <location_countries>
    <country>Norway</country>
  </location_countries>
  <link>
    <url>http://www.ntnu.edu/cerg/generation100</url>
    <description>Generation 100 web page</description>
  </link>
  <verification_date>January 2014</verification_date>
  <lastchanged_date>January 20, 2014</lastchanged_date>
  <firstreceived_date>January 8, 2013</firstreceived_date>
  <responsible_party>
    <responsible_party_type>Sponsor</responsible_party_type>
  </responsible_party>
  <keyword>Exercise</keyword>
  <keyword>Elderly</keyword>
  <keyword>Blood volume</keyword>
  <keyword>Hemoglobin</keyword>
  <is_fda_regulated>No</is_fda_regulated>
  <has_expanded_access>No</has_expanded_access>
  <!-- Results have not yet been posted for this study                                -->
</clinical_study>
